News | December 06, 2023
Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
India had proposed for setting up the global standards for millets
The company has received Form 483 with three observations
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
The product has been in-licensed from Strides and will be commercialized by Amneal
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Subscribe To Our Newsletter & Stay Updated
